Cytotoxicity of two novel formulations of calcium phosphate cements: A comparative in vitro study

Artificial Organs

Volumn 29, Issue 2, 2005, Pages 114-121

  Rossa Jr , Carlos ^a   Marcantonio Jr , Elcio ^a   Santos, Luis A ^b   Boschi, Anselmo O ^b   Raddi, Maria Stella G ^c  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^c School of Dentistry of Araraquara   (Brazil)

Author keywords

Bone substitutes; Calcium phosphate cements; Cytotoxicity; Dental cements

Indexed keywords

CALCIUM PHOSPHATE; CELL PROLIFERATION; CEMENTS; DENTAL CEMENT; HYDROXYAPATITE;

BONE SUBSTITUTES; CALCIUM PHOSPHATE CEMENT; CELL-BE; CELL/B.E; CELL/BE; FIBROBLASTIC CELLS; HYDROXYAPATITE CEMENTS; IN-VITRO; NEGATIVE CONTROL; VITRO STUDIES;

CYTOTOXICITY;

ALPHA CALCIUM PHOSPHATE; BETA CALCIUM PHOSPHATE; BIOMATERIAL; CALCIUM PHOSPHATE; CEMENT; HYDROXYAPATITE; UNCLASSIFIED DRUG; TOOTH CEMENT;

ANIMAL CELL; ARTICLE; BONE PROSTHESIS; CELL COUNT; CELL LINEAGE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG FORMULATION; FIBROBLAST; KRUSKAL WALLIS TEST; NONHUMAN; PRIORITY JOURNAL; CELL CULTURE; CELL SURVIVAL; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; METHODOLOGY; TOXICITY TESTING;

ANIMALIA;

CALCIUM PHOSPHATES; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DENTAL CEMENTS; FIBROBLASTS; HUMANS; TOXICITY TESTS;

EID: 20544451326     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2005.29022.x     Document Type: Article

References (21)

1. Garrett S. Periodontal regeneration around natural teeth. Ann Periodontol 1996;1:621-66.
2. Rosenberg E, Rose LF. Biologic and clinical considerations for autografts and allografts in periodontal regeneration therapy. Dent Clin North Am 1998;42:467-90.
3. Constantino PD, Friedman CD. Synthetic bone graft substitutes. Otolaryngol Clin North Am 1994;27:1037-74.
4. Gruninger SE, Siew C, Chow LC, O'Young A, Ts'ao NK, Brown WE. Evaluation of the biocompatibility of a new calcium-phosphate setting cement. J Dent Res 1984;63:200.
5. Hong YC, Wang JT, Hong CY, Brow WE, Chow LC. The periapical tissue reactions to a calcium phosphate cement in the teeth of monkeys. J Biomed Mat Res 1991;25:485-98.
6. Brown GD, Mealey BL, Nummikoski PV, Bifano SL, Waldrop TC. Hydroxyapatite cement implant for regeneration of periodontal osseous defects in humans. J Periodontol 1998;69:146-57.
7. Miyamoto Y, Ishikawa K, Fukao H, et al. In vivo setting behavior of fast-setting calcium phosphate cement. Biomaterials 1995;16:855-60.
8. Bifano CA, Edgin WA, Colleton C, Bifano SL, Constantino PD. Preliminary evaluation of hydroxyapatite cement as an augmentation device in the edentulous atrophic canine mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:512-6.
9. Blom EJ, Klein-Nulend J, Yin L, van Waas MA, Burger EH. Transforming growth factor-betal incorporated in calcium phosphate cement stimulates osteotransductivity in rat calvarial bone defects. Clin Oral Implants Res 2001;12:609-16.
10. Zoulgami M, Lucas A, Briard P, Gaude J. A self-setting single-component calcium phosphate cement. Biomaterials 2001;22:1933-7.
11. Sarkar MR, Wachter N, Patka P, Kinzl L. First histological observations on the incorporation of a novel calcium phosphate bone substitute material in human cancellous bone. J Biomed Mater Res 2001;58:329-34.
12. Yokoyama A, Yamamoto S, Kawasaki T, Kohgo T, Nakasu M. Development of calcium phosphate cement using chitosan and citric acid for bone substitute materials. Biomaterials 2002;23:1091-101.
13. Santos AR Jr, Barbanti SH, Duek EA, Dolder H, Wada RS, Wada ML. Vero cell growth and differentiation on poly(Llactic acid) membranes of different pore diameters. Artif Organs 2001;25:7-13.
14. 4) 2 system: pH, workability and setting times. J Mat Sci Mat Medical 1999;10:223-30.
15. Ishikawa K, Miyamoto Y, Suzuki K, Nagayama M. Mechanism of inflamatory response to calcium phosphate cement. J Dent Res 1998;1446:812.
16. Miyamoto Y, Ishikawa K, Takechi M, et al. Histological and compositional evaluations of three types of calcium phosphate cements when implanted in subcutaneous tissue immediately after mixing. J Biom Mat Res 1999;48:36-42.
17. Oreffo ROC, Driessens FCM, Planell JA, Triffitt JT. Growth and differentiation of human bone marrow osteoprogenitors on novel calcium phosphate cements. Biomaterials 1998;19: 1845-54.
18. Doi Y, Shimizu Y, Moriwaki Y, et al. Development of a new calcium phosphate cement that contains sodium calcium phosphate. Biomaterials 2001;22:847-54.
19. Yang A, Cardona DL, Barile FA. Subacute cytotoxicity testing with cultured human lung cells. Toxicol Vitro 2002;16:33-9.
20. Segev A, Aviezer D, Safran M, Gross Z, Yayon A. Inhibition of vascular smooth muscle cell proliferation by a novel fibroblast growth factor receptor antagonist. Cardiovasc Res 2002;53:232-41.
21. Estrada-Garcia L, Carrera-Rotllan J, Puig-Parellada P. Effects of oxidative stress and antioxidant treatments on eicosanoid synthesis and lipid peroxidation in long term human umbilical vein endothelial cells culture. Prostaglandins Other Lipid Med 2002;67:13-25.